PE-Backed Drug Developer Case Study

A private equity-backed biopharmaceutical drug developer develops indication roadmap for phase 3 clinical trials and commercialization.

Read more: PE-Backed Drug Developer Case Study


Joe Giandomenico

Joe Giandomenico

Manager, Boston

Recent Posts

C5ISRT and the Future of Convergence Warfare

From sense to sense-making to actionable intelligence: Data convergence is at the center of the DoD’s new Joint Warfighting Concept. Convergence of mission areas and traditional concepts is challenging the acquisition process and the Defense Industry to be positioned to meet warfighter needs.

Turning the Tables: America and the New Threat Landscape

This past decade has seen the rise of near-peer and peer adversaries with sophisticated capabilities that challenge the ability of the U.S. military to project power. This new threat environment is driving the need for new National Security and Defense Strategies.

Follow Us